Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2020-07-13 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2020-07-13 English
FORM 4
Director's Dealing
2020-07-13 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 15, 2020, reporting the results of the 2020 Annual Meeting of Stockholders for Medpace Holdings, Inc. It details the voting outcomes on several proposals including election of directors, ratification of the independent auditor, and advisory votes on executive compensation. The content focuses on the submission of matters to a vote of security holders and the official voting results. There is no detailed financial data, management discussion, or full report content. The document is not an annual or quarterly report, nor a proxy solicitation, but specifically reports voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4444 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report publication.
2020-05-21 English
FORM 4
Director's Dealing
2020-05-19 English
FORM 4
Director's Dealing
2020-05-19 English
FORM 4
Director's Dealing
2020-05-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.